US 6632962
Caspase inhibitors and uses thereof
expired A61PA61P1/04A61P1/16
Quick answer
US patent 6632962 (Caspase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P1/04, A61P1/16, A61P1/18, A61P13/12